Nuclear EGFR characterize still controlled proliferation retained in better differentiated clear cell RCC.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Renal cell carcinoma (RCC) is a prevalent kidney cancer with a 2-3% cancer incidence, often diagnosed with metastases.
• RCC exhibits resistance to radio and chemotherapy, necessitating novel prognostic markers.
• The prognostic significance of epidermal growth factor receptor (EGFR) in RCC is debated due to varying histological types and evaluation methods.

Purpose of the Study:

• To investigate the prognostic value of EGFR expression localization in renal cell carcinoma.
• To explore the association between membranous and nuclear EGFR expression and tumor characteristics.
• To hypothesize the role of nuclear EGFR signaling in well-differentiated RCC with favorable prognosis.

Main Methods:

• Analysis of membranous and nuclear EGFR expression in RCC tumor samples.
• Correlation of EGFR expression patterns with tumor grade (Fuhrman nuclear grade) and differentiation.
• Evaluation of associations between EGFR localization and patient prognosis.

Main Results:

• Membranous EGFR expression correlated with high nuclear grade and poorly differentiated RCC tumors.
• Nuclear EGFR expression was found in low nuclear graded, well-differentiated tumors, associated with good prognosis.
• These findings suggest distinct roles for EGFR localization in RCC progression.

Conclusions:

• EGFR's subcellular localization is a critical determinant of its prognostic value in renal cell carcinoma.
• Nuclear EGFR expression may indicate controlled proliferation and a favorable prognosis in well-differentiated RCC (Fuhrman nuclear grade I or II).
• Membranous EGFR expression is linked to aggressive tumor features and poorer outcomes.